Cuijie Wei
Impact in
-
- Alkaloids: synthesis and pharmacology
-
- Traditional and Medicinal Uses of Annonaceae
Papers in
-
- Muscle Physiology and Disorders 11
- RNA Research and Splicing 5
- RNA modifications and cancer 4
- Mitochondrial Function and Pathology 4
- Genetics 7
- Neurogenetic and Muscular Disorders Research 7
- Co-authors
- Hui Xiong (18 shared papers)Zhiwen Liu (2 shared papers)Xiao‐Qi Zhang (2 shared papers)Wen‐Cai Ye (2 shared papers)Haipo Yang (5 shared papers)Shuo Wang (2 shared papers)Dongdong Qin (1 shared paper)Man Li (1 shared paper)
- Journals
- Frontiers in Neurology (3 papers)Gene (2 papers)Frontiers in Pediatrics (2 papers)Orphanet Journal of Rare Diseases (2 papers)Human Gene Therapy (1 paper)
- Partner nations
- ChinaUnited StatesMacao
In The Last Decade
Cuijie Wei
24 papers receiving 129 citations
Peers
Comparison fields: 5 of 51
- Pharmacology 29
- Biochemistry 18
- Toxicology 5
- Genetics 12
- Molecular Biology 76
Countries citing papers authored by Cuijie Wei
This map shows the geographic impact of Cuijie Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cuijie Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cuijie Wei more than expected).
Fields of papers citing papers by Cuijie Wei
This network shows the impact of papers produced by Cuijie Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cuijie Wei. The network helps show where Cuijie Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Cuijie Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 23 | |
| 2 | 2019 | 22 | |
| 3 | 2020 | 19 | |
| 4 | 2016 | 12 | |
| 5 | 2012 | 9 | |
| 6 | 2023 | 6 | |
| 7 | 2022 | 6 | |
| 8 | 2021 | 5 | |
| 9 | 2021 | 4 | |
| 10 | 2023 | 3 | |
| 11 | 2022 | 3 | |
| 12 | 2022 | 3 | |
| 13 | 2023 | 2 | |
| 14 | [Duchenne and Becker muscular dystrophy complicated with epilepsy]. | 2015 | 2 |
| 15 | [Clinical and molecular genetic analysis of a family with normokalemic periodic paralysis]. | 2013 | 2 |
| 16 | 2025 | 1 | |
| 17 | [Value of muscle enzyme analysis in differential diagnosis of childhood myopathic hyper-creatine kinase-emia]. | 2014 | 1 |
| 18 | 2024 | 1 | |
| 19 | 2022 | 1 | |
| 20 | 2022 | 1 |
About Cuijie Wei
Cuijie Wei is a scholar working on Molecular Biology, Genetics, Cellular and Molecular Neuroscience, Physiology and Cardiology and Cardiovascular Medicine, having authored 28 papers that have together received 130 indexed citations. Recurring topics across this work include Muscle Physiology and Disorders (11 papers), Neurogenetic and Muscular Disorders Research (7 papers), RNA Research and Splicing (5 papers), Genetic Neurodegenerative Diseases (4 papers), RNA modifications and cancer (4 papers), Mitochondrial Function and Pathology (4 papers), Metabolism and Genetic Disorders (3 papers) and Cardiomyopathy and Myosin Studies (3 papers). The work is most often cited by research in Pharmacology (29 citations), Biochemistry (18 citations), Toxicology (5 citations), Genetics (12 citations) and Molecular Biology (76 citations). Cuijie Wei has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Hui Xiong, Zhiwen Liu, Xiao‐Qi Zhang, Wen‐Cai Ye, Haipo Yang, Shuo Wang, Dongdong Qin, Man Li, Dongmei Zhang and Shu Zhang. Their work appears in journals such as Frontiers in Neurology, Gene, Frontiers in Pediatrics, Orphanet Journal of Rare Diseases and Human Gene Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.